Skip to content
AIPressRoom

FundingHealthcare & Biotech

XRlabs Raises $8.4M to Expand Surgical AI Platform

XRlabs raised $8.4M Seed funding led by Playground Global to advance its AI platform for real-time surgical guidance and OR integration.

XRlabs raises $8.4M

The big picture: London-based medical technology company XRlabs has raised $8.4 million in seed funding to advance its artificial intelligence platform, which provides real-time surgical guidance and integrates with existing operating room equipment.

Why it matters:

  • Enhanced Surgical Outcomes: XRlabs’ platform aims to improve surgical precision and safety by providing critical, real-time intelligence to surgical teams, leveraging data that is often underutilized during procedures.
  • Seamless Integration: The device-agnostic software operates as an external AI layer, allowing hospitals to upgrade their capabilities without the significant cost and disruption of replacing existing surgical equipment.
  • Global Expansion: The funding will support regulatory development and clinical deployments across the UK, Europe, and the United States, addressing a critical need for advanced surgical AI solutions worldwide.

How it works:

  • Computer Vision & Deep Learning: The platform uses advanced computer vision and deep learning to analyze live surgical video, delivering actionable insights to surgical teams during operations.
  • Unified Data View: It combines live surgical video, navigation data, and preoperative CT and MRI scans into a single, comprehensive view of surgical anatomy, compatible with high-resolution 4K 3D scopes.
  • NVIDIA Partnership: As an NVIDIA partner in robotics, XRlabs leverages NVIDIA Jetson Thor and Isaac for Healthcare technologies to develop sophisticated surgical perception, instrument tracking, and automation capabilities.

The catch: Integrating new AI technologies into highly regulated and complex environments like operating rooms presents significant challenges, including stringent regulatory approvals, data privacy concerns, and the need for extensive clinical validation. While XRlabs’ device-agnostic approach mitigates some hardware integration hurdles, widespread adoption will depend on demonstrating clear clinical benefits and navigating competitive landscapes with established medical device manufacturers.

Key Facts

  • Company: XRlabs
  • Amount: $8.4M
  • Round: Seed
  • Investors: Playground Global (lead), Eka Ventures
  • Founder: Dr. Ali Haddad
  • Sector: Surgical AI Infrastructure
  • Headquarters: London, UK

AIPressRoom Weekly

Every round we reported this week, the people behind the companies, and the events coming up. One email, every Tuesday.

More in Healthcare & Biotech

All